Gossamer Bio, Inc. (GOSS)
8.86
-0.04
(-0.51%)
USD |
NASDAQ |
Oct 15, 11:52
Gossamer Bio Total Long Term Debt (Quarterly) : 39.10M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.10M |
| March 31, 2026 | 201.98M |
| December 31, 2025 | 201.97M |
| September 30, 2025 | 201.96M |
| June 30, 2025 | 201.94M |
| March 31, 2025 | 201.93M |
| December 31, 2024 | 201.92M |
| September 30, 2024 | 201.88M |
| June 30, 2024 | 197.05M |
| March 31, 2024 | 206.41M |
| December 31, 2023 | 209.16M |
| September 30, 2023 | 212.60M |
| June 30, 2023 | 216.02M |
| March 31, 2023 | 219.40M |
| December 31, 2022 | 222.76M |
| September 30, 2022 | 226.16M |
| June 30, 2022 | 217.90M |
| March 31, 2022 | 229.95M |
| Date | Value |
|---|---|
| December 31, 2021 | 182.34M |
| September 30, 2021 | 181.33M |
| June 30, 2021 | 181.84M |
| March 31, 2021 | 180.94M |
| December 31, 2020 | 180.10M |
| September 30, 2020 | 179.47M |
| June 30, 2020 | 177.21M |
| March 31, 2020 | 36.65M |
| December 31, 2019 | 37.20M |
| September 30, 2019 | 37.71M |
| June 30, 2019 | 38.22M |
| March 31, 2019 | 10.54M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 6.04M |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| United Therapeutics Corp. | 0.00 |
| Arbutus Biopharma Corp. | 3.111M |
| Kura Oncology, Inc. | 23.16M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |